Corneal opacities secondary to topical naphazoline and antazoline (Albalon-A).
D000328:Adult; D000865:Antazoline / Q000009:adverse effects*; D003318:Corneal Opacity / Q000139:chemically induced*; D004338:Drug Combinations / Q000009:adverse effects; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects*; D008297:Male; D009278:Naphazoline / Q000009:adverse effects*; D009883:Ophthalmic Solutions; D014786:Vision Disorders / Q000139:chemically induced
D004338:Drug Combinations; D007093:Imidazoles; D009883:Ophthalmic Solutions; C051139:antazoline sulfate, naphazoline mononitrate drug combination; D000865:Antazoline; D009278:Naphazoline